Ryotaro Sakamori

45PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Respiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 11, 2026
Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

|May 07, 2026
Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

|Mar 24, 2026
Impact of Treatment Response to Anticoagulant Therapy on Liver-Related Events in Patients With Cirrhosis and Portal Vein Thrombosis.

Atsushi Maeda, Yuki Tahata, Hayato Hikita

|Sep 09, 2025
Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma.

Kazuki Maesaka, Hayato Hikita, Machiko Kai

|Jun 16, 2025
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide Analogs.

Kazuhiro Murai, Hayato Hikita, Ryoko Yamada

|Nov 04, 2024
Unveiling the dynamics of hepatitis C virus transmission among injection drug users and men who have sex with men: A comprehensive study in Japan.

Zayar Phyo, Satoshi Tanaka, Aya Sugiyama

Pageof 8

Frequent Collaborators

27 joint publications

Takahiro Kodama

23 joint publications

Tetsuo Takehara

18 joint publications

Hayato Hikita

10 joint publications

Kazuhiro Murai